Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan

Annals of Hematology

Volumn 86, Issue 1, 2007, Pages 49-54

  Komatsu, Tsunehiko ^a   Narimatsu, Hiroto ^b   Yoshimi, Ai ^a   Kurita, Naoki ^a   Kusakabe, Manabu ^a   Hori, Akiko ^d   Murashige, Naoko ^c   Matsumura, Tomoko ^d   Kobayashi, Kazuhiko ^c   Yuji, Koichiro ^d   Tanaka, Yuji ^d   Kami, Masahiro ^d  

^a Tsukuba Memorial Hospital   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JR Tokyo General Hospital   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Engraftment; Fludarabine; Reduced intensity stem cell transplantation; Tacrolimus; Total body irradiation; Umbilical cord blood

Indexed keywords

BUSULFAN; CYCLOSPORIN; FLUDARABINE; HLA ANTIGEN; STEROID; TACROLIMUS; THALIDOMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG HEMORRHAGE; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PILOT STUDY; PNEUMONIA; PRIORITY JOURNAL; STOMATITIS; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; VOMITING;

ADULT; AGED; BUSULFAN; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG THERAPY, COMBINATION; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PILOT PROJECTS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 33846441208     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-006-0190-5     Document Type: Article

References (13)

1. Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragan E, Jimenez C, Larrea L, Martin G, Martinez J, Jarque I, Moscardo F, Plume G, Andreu R, Regadera AI, Garcia I, Molla S, Solves P, de La Rubia J, Bolufer P, Benlloch L, Soler MA, Marty ML, Sanz MA (2001) Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies. Blood 98:2332-2338
2. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E (2004) Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351:2276-2285
3. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265-2275
4. Miyakoshi S, Yuji K, Kami M, Kusumi E, Kishi Y, Kobayashi K, Murashige N, Hamaki T, Kim SW, Ueyama J, Mori S, Morinaga S, Muto Y, Masuo S, Kanemaru M, Hayashi T, Takaue Y, Taniguchi S (2004) Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 10:3586-3592
5. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE (2003) Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 102:1915-1919
6. Narimatsu H, Matsumura T, Kami M, Miyakoshi S, Kusumi E, Takagi S, Miura Y, Kato D, Inokuchi C, Myojo T, Kishi Y, Murashige N, Yuji K, Masuoka K, Yoneyama A, Wake A, Morinaga S, Kanda Y, Taniguchi S (2005) Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 11:429-436
7. Kishi Y, Miyakoshi S, Kami M, Ikeda M, Katayama Y, Murashige N, Kusumi E, Yuji K, Kobayashi K, Kato D, Hamaki T, Matsumura T, Kim SW, Morinaga S, Mori S, Kanemaru M, Hayashi T, Takaue Y, Taniguchi S (2004) Early central nervous system complications after reduced-intensity stem cell transplantation. Biol Blood Marrow Transplant 10:561-568
8. Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, Gondo H, Tsuchida M, O H, Harada M, Asano S, Juji T, Sasazuki T, Takaku F (1999) Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan marrow donor program: Confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant 24:995-1003
9. Nishihira H, Kato K, Isoyama K, Takahashi TA, Kai S, Kato S, Takanashi M, Sato N, Sato H, Kitajima K, Naoe T, Saito H (2003) The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: An evaluation of graft-versus-host disease prophylaxis. Br J Haematol 120:516-522
10. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176-181
11. Thiede C, Florek M, Bornhauser M, Ritter M, Mohr B, Brendel C, Ehninger G, Neubauer A (1999) Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 23:1055-1060
12. Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18:695-706
13. Hori A, Kami M, Kim SW, Murashige N, Sakiyama M, Kojima R, Hamaki T, Makimoto A, Miyakoshi S, Masuo S, Taniguchi S, Kunitoh H, Takaue Y (2004) Urgent need for a validated tumor response evaluation system for use in immunotherapy. Bone Marrow Transplant 33:255-256